XML 23 R10.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Fair Value Measurements and Investments | 9 Months Ended
--- | ---
Mar. 30, 2018
Fair Value Disclosures [Abstract] |
Fair Value Measurements and Investments | Fair Value Measurements and Investments The Company’s total cash, cash equivalents and available-for-sale securities was as follows:
| March 30, 2018 |  | June 30, 2017
| (in millions)
Cash and cash equivalents | $ | 4,963 |  |  | $ | 6,354 |
Short-term available-for-sale securities | 20 |  |  | 24 |
Long-term available-for-sale securities (included within other non-current assets) | 93 |  |  | 94 |
Total cash, cash equivalents and available-for-sale securities | $ | 5,076 |  |  | $ | 6,472 |
Financial Instruments Carried at Fair Value Financial assets and liabilities that are remeasured and reported at fair value at each reporting period are classified and disclosed in one of the following three levels:
Level 1. | Quoted prices in active markets for identical assets or liabilities.
Level 2. | Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3. | Inputs that are unobservable for the asset or liability and that are significant to the fair value of the assets or liabilities.
The following tables present information about the Company’s financial assets and liabilities that are measured at fair value on a recurring basis as of March 30, 2018 and June 30, 2017, and indicate the fair value hierarchy of the valuation techniques utilized to determine such values:
| March 30, 2018
| Level 1 |  | Level 2 |  | Level 3 |  | Total
| (in millions)
Assets: |  |  |  |  |  |  |
Cash equivalents: |  |  |  |  |  |  |
Money market funds | $ | 2,353 |  |  | $ | — |  |  | $ | — |  |  | $ | 2,353 |
Certificates of deposit | — |  |  | 6 |  |  | — |  |  | 6 |
Total cash equivalents | 2,353 |  |  | 6 |  |  | — |  |  | 2,359 |
Short-term investments: |  |  |  |  |  |  |
U.S. Treasury securities | 3 |  |  | — |  |  | — |  |  | 3 |
Corporate notes and bonds | — |  |  | 14 |  |  | — |  |  | 14 |
Asset-backed securities | — |  |  | 1 |  |  | — |  |  | 1 |
Municipal notes and bonds | — |  |  | 1 |  |  | — |  |  | 1 |
Equity securities | 1 |  |  | — |  |  | — |  |  | 1 |
Total short-term investments | 4 |  |  | 16 |  |  | — |  |  | 20 |
Long-term investments: |  |  |  |  |  |  |
U.S. Treasury securities | 2 |  |  | — |  |  | — |  |  | 2 |
U.S. Government agency securities | — |  |  | 5 |  |  | — |  |  | 5 |
International government securities | — |  |  | 1 |  |  | — |  |  | 1 |
Corporate notes and bonds | — |  |  | 65 |  |  | — |  |  | 65 |
Asset-backed securities | — |  |  | 9 |  |  | — |  |  | 9 |
Municipal notes and bonds | — |  |  | 11 |  |  | — |  |  | 11 |
Total long-term investments | 2 |  |  | 91 |  |  | — |  |  | 93 |
Foreign exchange contracts | — |  |  | 24 |  |  | — |  |  | 24 |
Interest rate swap contract | — |  |  | 14 |  |  | — |  |  | 14 |
Total assets at fair value | $ | 2,359 |  |  | $ | 151 |  |  | $ | — |  |  | $ | 2,510 |
Liabilities: |  |  |  |  |  |  |
Foreign exchange contracts | $ | — |  |  | $ | 10 |  |  | $ | — |  |  | $ | 10 |
Total liabilities at fair value | $ | — |  |  | $ | 10 |  |  | $ | — |  |  | $ | 10 |
| June 30, 2017
| Level 1 |  | Level 2 |  | Level 3 |  | Total
| (in millions)
Assets: |  |  |  |  |  |  |
Cash equivalents: |  |  |  |  |  |  |
Money market funds | $ | 2,836 |  |  | $ | — |  |  | $ | — |  |  | $ | 2,836 |
Certificates of deposit | — |  |  | 10 |  |  | — |  |  | 10 |
Total cash equivalents | 2,836 |  |  | 10 |  |  | — |  |  | 2,846 |
Short-term investments: |  |  |  |  |  |  |
Corporate notes and bonds | — |  |  | 11 |  |  | — |  |  | 11 |
Asset-backed securities | — |  |  | 7 |  |  | — |  |  | 7 |
Municipal notes and bonds | — |  |  | 2 |  |  | — |  |  | 2 |
Equity securities | 4 |  |  | — |  |  | — |  |  | 4 |
Total short-term investments | 4 |  |  | 20 |  |  | — |  |  | 24 |
Long-term investments: |  |  |  |  |  |  |
U.S. Treasury securities | 5 |  |  | — |  |  | — |  |  | 5 |
U.S. Government agency securities | — |  |  | 5 |  |  | — |  |  | 5 |
International government securities | — |  |  | 1 |  |  | — |  |  | 1 |
Corporate notes and bonds | — |  |  | 67 |  |  | — |  |  | 67 |
Asset-backed securities | — |  |  | 7 |  |  | — |  |  | 7 |
Municipal notes and bonds | — |  |  | 9 |  |  | — |  |  | 9 |
Total long-term investments | 5 |  |  | 89 |  |  | — |  |  | 94 |
Foreign exchange contracts | — |  |  | 16 |  |  | — |  |  | 16 |
Total assets at fair value | $ | 2,845 |  |  | $ | 135 |  |  | $ | — |  |  | $ | 2,980 |
Liabilities: |  |  |  |  |  |  |
Foreign exchange contracts | $ | — |  |  | $ | 8 |  |  | $ | — |  |  | $ | 8 |
Interest rate swap contract | — |  |  | 1 |  |  | — |  |  | 1 |
Exchange options | — |  |  | — |  |  | 1 |  |  | 1 |
Total liabilities at fair value | $ | — |  |  | $ | 9 |  |  | $ | 1 |  |  | $ | 10 |
During the three and nine months ended March 30, 2018, the Company had no transfers of financial assets and liabilities between Level 1 and Level 2. Available-for-Sale Securities The cost basis of the Company’s investments classified as available-for-sale securities, individually and in the aggregate, approximated its fair value as of March 30, 2018 and June 30, 2017. The cost basis and fair value of the Company’s investments classified as available-for-sale securities as of March 30, 2018, by remaining contractual maturity, were as follows:
| Cost Basis |  | Fair Value
| (in millions)
Due in less than one year (short-term investments) | $ | 22 |  |  | $ | 20 |
Due in one to five years (included in other non-current assets) | 95 |  |  | 93 |
Total | $ | 117 |  |  | $ | 113 |
The Company determined available-for-sale securities had no material other-than-temporary impairments in the three and nine months ended March 30, 2018 or March 31, 2017. Financial Instruments Not Carried at Fair Value The carrying value of the Company’s revolving credit facility approximates its fair value given the revolving nature of the balance and the variable market interest rate. For financial instruments where the carrying value (which includes principal adjusted for any unamortized issuance costs, and discounts or premiums) differs from fair value (which is based on quoted market prices), the following table represents the related carrying value and fair value for each of the Company’s outstanding financial instruments. Each of the financial instruments presented below was categorized as Level 2 for all periods presented, based on the frequency of trading immediately prior to the end of the third quarter of 2018 and the fourth quarter of 2017, respectively.
| March 30, 2018 |  | June 30, 2017
| Carrying Value |  | Fair Value |  | Carrying Value |  | Fair Value
| (in millions)
0.50% convertible senior notes due 2020 | $ | 31 |  |  | $ | 36 |  |  | $ | 30 |  |  | $ | 34 |
Variable interest rate Term Loan A maturing 2021 | — |  |  | — |  |  | 4,074 |  |  | 4,130 |
Variable interest rate Term Loan A-1 maturing 2023 | 5,013 |  |  | 5,047 |  |  | — |  |  | — |
Variable interest rate U.S. Term Loan B-2 maturing 2023 | — |  |  | — |  |  | 2,968 |  |  | 2,989 |
Variable interest rate U.S. Term Loan B-3 maturing 2023 | 2,452 |  |  | 2,470 |  |  | — |  |  | — |
Variable interest rate Euro Term Loan B-2 maturing 2023(1) | — |  |  | — |  |  | 1,000 |  |  | 1,010 |
7.375% senior secured notes due 2023 | — |  |  | — |  |  | 1,835 |  |  | 2,062 |
1.50% convertible notes due 2024 | 924 |  |  | 1,192 |  |  | — |  |  | — |
10.50% senior unsecured notes due 2024 | — |  |  | — |  |  | 3,244 |  |  | 3,956 |
4.750% senior unsecured notes due 2026 | 2,280 |  |  | 2,301 |  |  | — |  |  | — |
Total | $ | 10,700 |  |  | $ | 11,046 |  |  | $ | 13,151 |  |  | $ | 14,181 |
(1) | Euro Term Loan B-2 outstanding principal amount as of June 30, 2017 was based upon the Euro to U.S. dollar exchange rate as of that respective date.
Cost Method Investments From time to time, the Company enters into certain strategic investments for the promotion of business and strategic objectives. The Company reports these investments under the cost method of accounting as it does not have a significant influence over the operations of these investees. These investments consist of debt and equity securities of privately-held companies that do not have a readily determinable fair value and are carried at historical cost. The Company assesses these securities for indications of other-than-temporary impairments. During the three and nine months ended March 30, 2018, the Company recorded impairment charges and losses related to the sale of these cost method investments of $9 million and $15 million, respectively, which were included in Other expense, net in the Condensed Consolidated Statements of Operations. During the three and nine months ended March 31, 2017, the Company recorded impairment charges and losses related to the sale of these cost method investments of $7 million and $11 million, respectively. As of March 30, 2018 and June 30, 2017, these investments aggregated $28 million and $91 million, respectively, and are reported under Other non-current assets in the Condensed Consolidated Balance Sheets.

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -URI http://asc.fasb.org/topic&trid=2155941 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration